Why Vir Biotechnology Jumped Nearly 19% Today
Shares of biopharma company Vir Biotechnology (NASDAQ: VIR) are up 18.9% as of 3:42 p.m. ET Friday following Thursday's post-close release of its third-quarter results. Earnings dramatically exceeded expectations due to strong sales of a COVID-19 treatment, but it's Vir's pipeline and partnerships that may be doing the bulk of today's bullish work.